Insider · CIK 0001648010
Diane C. Young
Files at CLDX (Celldex Therapeutics, Inc.). First filing -, latest -.
Diane C. Young files SEC Form 4 as officer at CLDX (Celldex Therapeutics, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Diane C. Young has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 2 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 25, 2026 | CLDX Celldex Therapeutics, Inc. | AGrant or award Incentive Stock Option (right to buy)derivative | +57,000 | $0.00 | $0 | 57,000 | Jun 29, 2026 |
| Jun 5, 2025 | CLDX Celldex Therapeutics, Inc. | AGrant or award Incentive Stock Option (right to buy)derivative | +72,000 | $0.00 | $0 | 72,000 | Jun 9, 2025 |
Questions about Diane C. Young
Answered from the filings on this page, as of the latest one.
Is Diane C. Young buying or selling?
Diane C. Young has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Diane C. Young's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Diane C. Young has 0.
Where does Diane C. Young file Form 4?
Diane C. Young has filed Form 4 at CLDX (Celldex Therapeutics, Inc.) as SVP, CHIEF MEDICAL OFFICER. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.